- Stevanato Group Reports Financial Results for the First Quarter of 2024
- Stevanato Group to Present at the Bank of America Securities Healthcare Conference
- Stevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024
- Stevanato Group appoints Ugo Gay as Chief Operations Officer
- Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares
- Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares
- Stevanato Group Announces Public Offering of Ordinary Shares
- Stevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum
- Stevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023
- Stevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 21.00 |
---|---|
High | 22.40 |
Low | 20.51 |
Bid | 22.00 |
Offer | 23.00 |
Previous close | 21.10 |
Average volume | 830.74k |
---|---|
Shares outstanding | 301.89m |
Free float | 71.05m |
P/E (TTM) | 35.63 |
Market cap | 6.37bn USD |
EPS (TTM) | 0.5922 USD |
Annual div (ADY) | 0.0578 USD |
---|---|
Annual div yield (ADY) | 0.27% |
Div ex-date | Jun 07 2023 |
Div pay-date | Jul 17 2023 |
Data delayed at least 15 minutes, as of May 11 2024 00:00 BST.
More ▼